IAA - Intranasal insulin and Abatacept trial
The ATIC-led IAA trial has commenced in Melbourne, with clinical trial centres to open in Adelaide, Perth, Brisbane and Sydney.
What does ATIC do?
ATIC is working across six distinct interconnected Domains to ensure maximum impact and fulfil our bold vision.
Clinical trials
Drive the implementation of immunotherapy clinical trials throughout Australia and New Zealand
Community engagement
Work closely with the type 1 diabetes community across the research cycle, from trial development through recruitment to communication of...
Data management
Harmonise data collection and ensure linkage with national and international diabetes networks.
Education and training
Train, equip and update clinicians, scientists and the wider community on the fundamentals of immunotherapy, as well as the latest...
Preclinical and translation
Attract immunotherapy trials to Australasia through innovation: the discovery of improved biomarkers, development of new therapies, and facilitation of biosample...
Regulation and government
Advocate for regulatory approval and government funding of immunotherapy treatments for type 1 diabetes.
Beyond Insulin - March seminar
The next seminar in our Beyond Insulin series will take place Thursday the 23rd of March from 1pm – 2pm. Dr Aveni Haynes will present her research using continuous glucose monitoring devices, which measure sugar levels in the body every 5 minutes for up to 10 days in a row, to investigate how and when sugar patterns change during the early stages of type 1 diabetes, in very young children at risk, before any symptoms or signs of the condition.
Verapamil in type 1 diabetes
March 2023
The human immune system works every minute of every day to keep the body healthy – through constant monitoring, and by tracking and destroying pathogens, such as disease-causing bacteria and viruses.
ATIC Town Hall Forum – video now available
February 2023
ATIC recently invited members of the type 1 diabetes community to learn more about ATIC – the first Australasian clinical trial collaborative set up to accelerate development and delivery of immunotherapy treatments for people with type 1 diabetes.
Baricitinib in the Treatment of Alopecia Areata
February 2023
5th seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series
We partner with global leaders in our field
Supported by
Coordinating Centre
